2-methyl-3-nitro-4-methoxymethyl-5-cyano-6-oxypyridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 80492 |
MeSH ID | M0090127 |
Synonym |
---|
AKOS000419193 |
2-methyl-3-nitro-4-methoxymethyl-5-cyano-6-oxypyridine |
3-pyridinecarbonitrile, 2-hydroxy-4-(methoxymethyl)-6-methyl-5-nitro- |
nsc 5867 |
nsc-5867 |
6281-75-0 |
nsc5867 |
3-cyano-4-methoxymethyl-5-nitro-6-methyl-(2-pyridone) |
STK833378 |
2-hydroxy-4-(methoxymethyl)-6-methyl-5-nitropyridine-3-carbonitrile |
2-hydroxy-4-(methoxymethyl)-6-methyl-5-nitronicotinonitrile |
4-(methoxymethyl)-6-methyl-5-nitro-2-oxo-1h-pyridine-3-carbonitrile |
A834016 |
AKOS005623355 |
2-hydroxy-4-methoxymethyl-6-methylnicotinonitrile |
13530-95-5 |
BBL028949 |
DTXSID90211921 |
2-methyl-3-nitro-4-methoxymethyl-5-cyano-6-pyridone |
2-methyl-3-nitro-4-methoxymethyl-5-cyano-6-hydroxypyridine |
4-(methoxymethyl)-6-methyl-5-nitro-2-oxo-1,2-dihydro-3-pyridinecarbonitrile |
VS-09040 |
4-(methoxymethyl)-6-methyl-5-nitro-2-oxo-1,2-dihydropyridine-3-carbonitrile |
STL195778 |
3-cyano-2-hydroxy-4-methoxymethyl-6-methyl-5-nitropyridine |
5-cyano-6-hydroxy-4-methoxymethyl-2-methyl-3-nitropyridine |
CS-0370698 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (16.67%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (83.33%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |